Poster Session 1-24 AML: Molecular Mechanism (1)

[PS1-24-3] Binimetinib exerts anti-leukemic effects under inactive status of PI3 kinase/Akt pathway

Kanae Sakakibara^1,2, Takayuki Tsujioka³, Junichiro Kida³, Nami Kurozumi^1,2, Takako Nakahara¹, Shinichiro Suemori³, Akira Kitanaka^1,3, Yujiro Arao², Kaoru Tohyama^1,3 (1.Medical Technology, Kawasaki University of Medical Welfare, Okayama, Japan, 2.Medical Technology, Okayama University, Okayama, Japan, 3.Laboratory Medicine, Kawasaki Medical School, Okayama, Japan)